Addus HomeCare (NASDAQ:ADUS) EVP Darby Anderson Sells 20,000 Shares

Key Points

  • EVP Darby Anderson sold 20,000 shares on Nov. 19 at an average of $109 for a total of $2.18M, cutting his holding by 31.18% to 44,144 shares (SEC filing).
  • Quarterly beat: Addus posted EPS of $1.56 (vs. $1.53 expected) and revenue of $362.3M, with revenue up about 25% year‑over‑year.
  • Market and analyst snapshot: Shares trade near $110 with a market cap of ~$2.03B and P/E ~24.3; analysts have a "Moderate Buy" consensus and an average price target of ~$137.11.

Addus HomeCare Corporation (NASDAQ:ADUS - Get Free Report) EVP Darby Anderson sold 20,000 shares of the business's stock in a transaction that occurred on Wednesday, November 19th. The shares were sold at an average price of $109.00, for a total value of $2,180,000.00. Following the completion of the transaction, the executive vice president owned 44,144 shares of the company's stock, valued at $4,811,696. This represents a 31.18% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this link.

Addus HomeCare Stock Up 1.0%

Shares of ADUS stock opened at $110.07 on Friday. The firm has a fifty day moving average of $114.83 and a 200-day moving average of $113.14. The company has a market capitalization of $2.03 billion, a price-to-earnings ratio of 24.30, a P/E/G ratio of 1.87 and a beta of 0.88. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.17. Addus HomeCare Corporation has a 12-month low of $88.96 and a 12-month high of $136.72.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings results on Monday, November 3rd. The company reported $1.56 EPS for the quarter, beating analysts' consensus estimates of $1.53 by $0.03. The company had revenue of $362.30 million for the quarter, compared to analyst estimates of $354.48 million. Addus HomeCare had a return on equity of 9.39% and a net margin of 6.51%.The company's quarterly revenue was up 25.0% compared to the same quarter last year. During the same period in the previous year, the company posted $1.30 earnings per share. As a group, equities research analysts predict that Addus HomeCare Corporation will post 4.59 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Addus HomeCare




A number of institutional investors have recently added to or reduced their stakes in the stock. Larson Financial Group LLC boosted its position in Addus HomeCare by 133.3% in the third quarter. Larson Financial Group LLC now owns 238 shares of the company's stock valued at $28,000 after buying an additional 136 shares in the last quarter. AlphaQuest LLC bought a new position in shares of Addus HomeCare in the 3rd quarter valued at $37,000. Wexford Capital LP acquired a new stake in shares of Addus HomeCare during the 3rd quarter valued at $41,000. State of Wyoming bought a new stake in Addus HomeCare during the 2nd quarter worth $47,000. Finally, BI Asset Management Fondsmaeglerselskab A S bought a new stake in shares of Addus HomeCare during the first quarter worth about $41,000. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on ADUS shares. TD Cowen raised their price target on shares of Addus HomeCare from $139.00 to $140.00 and gave the stock a "buy" rating in a research note on Wednesday, November 5th. Weiss Ratings reaffirmed a "hold (c+)" rating on shares of Addus HomeCare in a report on Wednesday, October 8th. Cowen reiterated a "buy" rating on shares of Addus HomeCare in a research note on Wednesday, November 5th. Stephens reissued an "overweight" rating and issued a $140.00 price target on shares of Addus HomeCare in a report on Wednesday, September 3rd. Finally, BMO Capital Markets assumed coverage on Addus HomeCare in a report on Thursday, November 13th. They set a "market perform" rating and a $120.00 price objective for the company. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $137.11.

View Our Latest Research Report on ADUS

Addus HomeCare Company Profile

(Get Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Featured Stories

Insider Buying and Selling by Quarter for Addus HomeCare (NASDAQ:ADUS)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Addus HomeCare?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Addus HomeCare and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles